Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05846516
Title A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amal Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CHE

Facility Status City State Zip Country Details
USC/Norris Comprehensive Center RECRUITING Los Angeles California 90033 United States Details
University of California Los Angeles (UCLA) RECRUITING Los Angeles California 90095 United States Details
University of Colorado Hospital RECRUITING Aurora Colorado 80045 United States Details
University of Florida RECRUITING Gainesville Florida 32610-0278 United States Details
Orlando Health RECRUITING Orlando Florida 32806 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
START - South Texas Accelerated Research Therapeutics RECRUITING San Antonio Texas 78229 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Virginia Mason Medical Center RECRUITING Seattle Washington 98101 United States Details
University Hospital of Lausanne (CHUV) RECRUITING Lausanne Default 1011 Switzerland Details
University Hospital of Bern (Inselspital) RECRUITING Bern 3010 Switzerland Details
University Hospitals of Geneva (HUG) RECRUITING Geneva 1205 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field